Reduced / Loss of Sense of Smell

A partial or total loss of the sense of smell, known as anosmia, or a distorted sense of smell, known as parosmia, can be temporary, due to an inflammation of the nasal tissues, or permanent. It can have a profound impact on quality of life.

Reduced / Loss of Sense of Smell

A partial or total loss of the sense of smell, known as anosmia, or a distorted sense of smell, known as parosmia, can be temporary, due to an inflammation of the nasal tissues, or permanent. It can have a profound impact on quality of life.

Causes of anosmia

Common conditions such as rhinitis, sinusitis or nasal polyps can cause a temporary loss of sense of smell. It can also be caused by degeneration of the sensitive cells for the reception of smell in the nose after a severe ‘cold’ or influenza. Smell can also be affected by a head injury, certain medications and medical conditions. Very rarely a tumour of the nerve for smell (olfactory nerve) can affect the sense of smell. Loss of sense of smell will require assessment and investigations as appropriate.

RHINITIS

Rhinitis literally means inflammation of the nose and refers to the inside lining of the nose. The inflammation causes swelling of the lining, excess mucus production and irritation. The swelling causes the sensation of blockage and the excessive mucus production leads to a runny nose and/or too much mucus going backwards from the nose to the throat known as post nasal drip. If the rhinitis is caused by an allergy then the patient may experience itching of the nose, eyes and throat. Rhinitis also causes sneezing.

Rhinitis is a very common condition. The severity of symptoms is extremely variable, however. Some people have mild nose irritation which comes and goes and causes little trouble and others have severe symptoms causing discomfort, distress and difficulty carrying out daily activities.

The causes of persistent rhinitis can be divided into allergic and non-allergic.

ALLERGIC RHINITIS

The most common allergies causing rhinitis are pollen (hay fever), house dust mite and pets, most commonly cats. Hay fever is seasonal and occurs during a particular period each year.

Symptoms of allergy in the nose are due to the immune system reacting to the allergen (the individual cause of the allergy). Cells in the lining of the nose release histamine and other chemicals when they come into contact with the allergen. This causes inflammation in the nose with swelling, excess mucus production and irritation. Allergic rhinitis can be associated with asthma and eczema and can run in families.

NON-ALLERGIC RHINITIS

Rhinitis commonly occurs without an allergic cause and there is often no identifiable cause for the condition. Many factors can influence the nasal lining however including:

  • Changes in temperature or humidity
  • Hormonal changes e.g. during pregnancy
  • Food and drink, e.g. alcohol
  • Emotion such as stress and anxiety
  • Medication. Some medications can have side effects on the nose e.g. blood pressure medication and the contraceptive pill
  • Use of decongestants

Rhinitis medicamentosa is the name given to rhinitis that can occur due to the overuse of nasal decongestant sprays. These sprays are used to relieve a blocked nose and they reduce swelling inside the nose by causing blood vessels in the nose to constrict. However, with prolonged use, they cause rebound nasal congestion which is more severe than the original swelling. The temptation is to use yet more decongestant and a vicious circle can be set up. A similar problem can occur in people who abuse cocaine.

In some people, no cause for their persistent rhinitis is found and it is called idiopathic or vasomotor rhinitis.

You may require allergy tests if allergic rhinitis is suspected. These can be in the form of skin prick tests or blood tests.

ALLERGIC RHINITIS

The commonly used treatment options for allergic rhinitis include:

  • Avoiding the cause of the allergy
  • Antihistamine tablets
  • Steroid nose sprays
  • Steroid nose drops and tablets (for limited periods)
  • Nasal Douching (this involves spraying salt water into the nose)

In some cases, other forms of medication are required. Severe allergic rhinitis can sometimes be treated with immunotherapy. This consists of a course of tablets or injections which modify your immune system in order to prevent the allergic reaction from occurring.

NON-ALLERGIC RHINITIS

The main form of treatment for this is a steroid nasal spray although sprays to reduce secretion from the nose and nasal douching are also used.

SURGERY

This can be indicated when medical treatment has failed or if the rhinitis is associated with sinusitis (see the section on sinusitis) or large adenoids (see the section on adenoids). Nasal surgery for rhinitis involves reducing the size of the nasal turbinates. These are extensions of the side wall of the nose which become swollen in rhinitis.

WEAKENED, LOST OR DISTORTED SENSE OF SMELL AFTER A SEVERE ‘COLD’, INFLUENZA OR COVID-19.

A weakened, lost or distorted sense of smell can also be caused by degeneration of the sensitive cells for the reception of smell in the nose after a severe ‘cold’, influenza or COVID-19.

Since the onset of the current pandemic, our consultant team have worked hard to contribute to our knowledge of this phenomenon. We published the first case series on healthcare workers in the UK and demonstrated a high incidence of self-reported anosmia amongst healthcare workers across different healthcare systems in the UK, which highlighted the need to address the long-term effects of these symptoms.

Crucially, this work identified that females, particularly those above forty years of age, and those with concurrent distorted perception of smell (parosmia), were more likely to experience persistent smell loss.

Based on the above, we have run one of the largest prospective multi-institutional clinical studies on Covid-19 associated anosmia in the UK, investigating the course of symptoms over one-year (COVANOS UK study). In brief, this study demonstrated that 70% of those, who experience smell problems due to Covid-19 infection, spontaneously recover within the first month.

However, the remaining 30% of participants continue to experience some degree of olfactory loss even after this time-point. Importantly, 60% of our participants who had objective smell loss at enrolment saw no improvement in their sense of smell at the one-year follow-up, implying that spontaneous recovery is more unlikely to occur if olfactory dysfunction persists beyond one month at the outset.

Ultimately, we confirm that, even though many will spontaneously recover their sense of smell shortly after onset, there is a significant proportion of individuals who will suffer long-term olfactory dysfunction, as seen at our one-year follow-up, with a high prevalence of continued objective olfactory loss and symptoms of a distorted sense of smell.

More recently, we have conducted a prevalence surveys in a representative sample (gender-matched and age-matched) of the UK (n=1,160) population. In the UK, the observed rates of persistent smell loss (beyond 12 months) and distorted were 1.0% and 0.9%, respectively, which is equivalent to 695,331 (95% CI: 398,416 – 1.2 million) and 637,386 (95% CI: 356,454 – 1.1 million) affected individuals, demonstrating the immense burden of long-term smell dysfunction due to COVID-19 (published in the journal Rhinology). We seeing affected patients both in the NHS and privately, are working with the charity Fifth Sense and are actively involved in ongoing research on this topic.

We offer comprehensive assessment and management of a weakened, lost or distorted sense of smell.

  1. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management. M. Lechner, … N. Eynon-Lewis, .. et al. Rhinology. 2020; doi:10.4193/Rhin20.189.
  2. International consensus statement on allergy and rhinology: Olfaction. Z.M. Patel, E.H. Holbrook, J.H. Turner, … , M. Lechner, … , C.H. Yan. International Forum of Allergy & Rhinology. 2022; 12(4):327-680; doi: 10.1002/alr.22929.
  3. Olfactory Loss of Function as a Possible Symptom of COVID-19. M. Lechner, Z.M. Patel, C. Philpott, V.J. Lund; JAMA Otolaryngology – Head and Neck Surgery. 2020,10.1001/jamaoto.2020.1589. doi:10.1001/jamaoto.2020.1589
  4. High prevalence of persistent smell loss and qualitative smell dysfunction during the Covid-19 pandemic in the United States: urgent need for clinical trials. M. Lechner, et al. International Forum of Allergy & Rhinology. 2022; doi: 10.1002/alr.23100.
  5. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom. M. Lechner, … N. Eynon-Lewis, …, et al. Rhinology. 2022; doi: 10.4193/Rhin22.232.
  6. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training. M. Lechner, … N. Eynon-Lewis, …, et al. Rhinology. 2022; doi: 10.4193/Rhin21.470.
  7. Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients. B. Shahrvini, D.P. Prajapati, M. Said, J. Liu, S. Srinivas, S. Jayaraj, V.J. Lund, A.S. DeConde, M. Lechner, C.H. Yan; Int Forum Allergy Rhinol. 2021; 11(8):1280-1282. doi: 10.1002/alr.22802
  8. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK. J. Makaronidis, C. Firman, C.G. Magee, J. Mok, N. Balogun, M. Lechner, A. Carnemolla, R.L. Batterham; BMC Infect Dis. 2021; 21(1):221. doi: 10.1186/s12879-021-05927-w.
  9. Course of symptoms for loss of sense of smell and taste over time in one thousand forty-one healthcare workers during the Covid-19 pandemic. M. Lechner, … N. Eynon-Lewis, …, et al.; Clinical Otolaryngology. 2020, doi: 10.1111/coa.13683.
  10. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection. M.Lechner, … N. Eynon-Lewis, …, et al.; The Lancet Microbe. 2020, 1(4): e150.
  11. Association of subjective olfactory dysfunction and 12‐item odor identification testing in ambulatory COVID‐19 patients. D.P. Prajapati, B. Shahrvini, B. Macdonald, Kavya L. Crawford, M. Lechner, A.S. DeConde, C.H. Yan; International Forum of Allergy & Rhinology. 2020; DOI: 10.1002/alr.22688
  12. Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends. G. Cherry, J. Rocke, M. Chu, J. Liu, M. Lechner, V.J. Lund, B.N. KumarLiu, M. Lechner, V.J. Lund, B.N. Kumar. Expert Rev Anti Infect Ther. 2020;1-6. doi:10.1080/14787210.2020.1792289

SINUSITIS

The sinuses are air-containing cavities situated in the cheeks, between the eyes and in the forehead. They produce mucus which drains into the nose and can be regarded as extensions of the nose. Rhinitis can be associated with blockage and inflammation of the sinuses (sinusitis).

Sinusitis can be ‘acute’, for example, when associated with a cold or flu or ‘chronic’ when the condition is ongoing.

As well as allergy tests the patient will require imaging of the sinuses to confirm the diagnosis. This is usually a CT scan although sometimes an MRI is performed.

Treatment consists of:

  • Treating associated rhinitis
  • Antibiotics
  • Decongestants (short term use only)
  • Steroids (sprays and drops mainly but occasionally a course of tablets)
  • Nasal douching (this involves passing salt water through the nose to remove secretions and allergic particles)
  • Surgery (when medical treatment is not successful)
SURGERY

Surgery involves opening the drainage points from the sinuses to the nose and removing inflamed tissue. The aim of the surgery is to enable the sinuses to secrete mucus freely into the nose without obstruction and to allow the lining of the sinuses to become healthy.

Surgery is performed using small endoscopes that project an image of the inside of the nose and sinuses onto a television monitor allowing the surgeon to operate with fine instruments inside the nose using the monitor as a guide. This is called endoscopic sinus surgery or functional endoscopic sinus surgery (FESS). No cuts are made on the outside of the nose or face. Sometimes small balloons are used to dilate passages between the nose and sinuses in a procedure called balloon sinuplasty.

NASAL POLYPS

These are ‘grape-like’ swellings inside the nose. They usually arise from the sinuses. Treatment consists of steroids which often shrink the polyps. If they are not controlled with medication then surgery to remove them will be offered.

They can be associated with asthma and sensitivity to non-steroidal anti-inflammatory drugs.

Polyps usually occur on both sides of the nose. If they occur on one side only they require investigation to exclude cancer of the nose and sinuses although a polyp in one side of the nose is often benign and not cancerous.

Polyps are often removed during sinus surgery which is usually performed under general anaesthetic (patient asleep) as a day case. Polypectomy can be performed alone under local anaesthetic (patient awake) when the inside of the nose is numbed before surgery. Polyps themselves are not actually sensitive and an instrument called a microdebrider can be used to detach the polyp and suction it out of the nose.

CONDITIONS TREATED

CONTACT

CLINICS

  • BMI The London Independent Hospital
  • London Bridge Hospital Part of HCA Healthcare UK
  • Hospital of St John & St Elizabeth